MPL
Company Details
Linkedin ID:
macleods-pharmaceuticals-ltd.
Website:
Employees number:
11,522
Number of followers:
126,567
NAICS:
3254
Industry Type:
Homepage:
macleodspharma.com
IP Addresses:
0
Company ID:
MAC_2163538
Scan Status:
In-progress
MACLEODS PHARMACEUTICALS LTD. Company CyberSecurity Posture
macleodspharma.com
A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.
MACLEODS PHARMACEUTICALS LTD. A.I CyberSecurity Scoring
MPL Risk Score (AI oriented)Between 750 and 799
MPL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
MPL Global Score (TPRM)XXXX
MPL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
MPL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
MPL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for MPL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2025.
Incident Types MPL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2025.
Incident History — MPL (X = Date, Y = Severity)
MPL cyber incidents detection timeline including parent company and subsidiaries
MPL Company Subsidiaries
A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.
Loading...
MPL Similar Companies
CVS Pharmacy is America’s leading retail pharmacy with more than 9,600 locations nationwide. For more than 50 years, CVS Pharmacy has offered customers the products and services they need to stay on their path to better health. In addition to our pharmacies, our stores feature on-trend beauty depart
Torrent Pharmaceuticals Ltd
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C
Johnson & Johnson Innovative Medicine
At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently addre
Merck Group
This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing t
Grifols
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions i
Hetero Drugs Ltd
Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm
Parexel
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more th
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor
.png)
MPL CyberSecurity News
October 04, 2025 05:30 AM
Girdhari Lal Bawri, Banwari Lal Bawri and Rajendra Agarwal
Three brothers, whose family owned a pharmacy in Jaipur, set up Macleods Pharmaceuticals in 1986 to make anti-TB medicines.
September 04, 2024 07:00 AM
Celebrating Pharma Excellence & Innovation: The 6th Elets Pharma Leadership Summit & Awards 2024
The event garnered deep insights into current trends, challenges, and opportunities, engaging over 175 senior delegates, industry leaders, and innovators.
July 31, 2021 04:51 PM
Girdhari Lal Bawri
Girdharilal Bawri is the chairman of Macleods Pharmaceuticals, which is among India's top 10 pharma firms. Bawri, whose family owned a pharmacy in Jaipur,...
May 09, 2021 11:58 AM
Banwari Lal Bawri
Banwari Lal Bawri is the joint managing director of privately held Macleods Pharmaceuticals, which is among India's top 10 pharma firms.
August 01, 2016 07:04 AM
Rajendra Agarwal
Medical doctor, whose family owned a pharmacy in Jaipur, set up Macleods Pharmaceuticals with his two brothers in 1986 to make anti-TB medicines.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
MPL CyberSecurity History Information
Official Website of MACLEODS PHARMACEUTICALS LTD.
The official website of MACLEODS PHARMACEUTICALS LTD. is https://www.macleodspharma.com.
MACLEODS PHARMACEUTICALS LTD.’s AI-Generated Cybersecurity Score
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD.’s AI-generated cybersecurity score is 774, reflecting their Fair security posture.
How many security badges does MACLEODS PHARMACEUTICALS LTD.’ have ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does MACLEODS PHARMACEUTICALS LTD. have SOC 2 Type 1 certification ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not certified under SOC 2 Type 1.
Does MACLEODS PHARMACEUTICALS LTD. have SOC 2 Type 2 certification ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. does not hold a SOC 2 Type 2 certification.
Does MACLEODS PHARMACEUTICALS LTD. comply with GDPR ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not listed as GDPR compliant.
Does MACLEODS PHARMACEUTICALS LTD. have PCI DSS certification ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. does not currently maintain PCI DSS compliance.
Does MACLEODS PHARMACEUTICALS LTD. comply with HIPAA ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not compliant with HIPAA regulations.
Does MACLEODS PHARMACEUTICALS LTD. have ISO 27001 certification ?
According to Rankiteo,MACLEODS PHARMACEUTICALS LTD. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD. operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD. employs approximately 11,522 people worldwide.
Subsidiaries Owned by MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD. presently has no subsidiaries across any sectors.
MACLEODS PHARMACEUTICALS LTD.’s LinkedIn Followers
MACLEODS PHARMACEUTICALS LTD.’s official LinkedIn profile has approximately 126,567 followers.
NAICS Classification of MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD. is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
MACLEODS PHARMACEUTICALS LTD.’s Presence on Crunchbase
No, MACLEODS PHARMACEUTICALS LTD. does not have a profile on Crunchbase.
MACLEODS PHARMACEUTICALS LTD.’s Presence on LinkedIn
Yes, MACLEODS PHARMACEUTICALS LTD. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/macleods-pharmaceuticals-ltd..
Cybersecurity Incidents Involving MACLEODS PHARMACEUTICALS LTD.
As of December 05, 2025, Rankiteo reports that MACLEODS PHARMACEUTICALS LTD. has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
MACLEODS PHARMACEUTICALS LTD. has an estimated 5,316 peer or competitor companies worldwide.
MACLEODS PHARMACEUTICALS LTD. CyberSecurity History Information
How many cyber incidents has MACLEODS PHARMACEUTICALS LTD. faced ?
Total Incidents: According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at MACLEODS PHARMACEUTICALS LTD. ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
Sigstore Timestamp Authority is a service for issuing RFC 3161 timestamps. Prior to 2.0.3, Function api.ParseJSONRequest currently splits (via a call to strings.Split) an optionally-provided OID (which is untrusted data) on periods. Similarly, function api.getContentType splits the Content-Type header (which is also untrusted data) on an application string. As a result, in the face of a malicious request with either an excessively long OID in the payload containing many period characters or a malformed Content-Type header, a call to api.ParseJSONRequest or api.getContentType incurs allocations of O(n) bytes (where n stands for the length of the function's argument). This vulnerability is fixed in 2.0.3.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description
Monkeytype is a minimalistic and customizable typing test. In 25.49.0 and earlier, there is improper handling of user input which allows an attacker to execute malicious javascript on anyone viewing a malicious quote submission. quote.text and quote.source are user input, and they're inserted straight into the DOM. If they contain HTML tags, they will be rendered (after some escaping using quotes and textarea tags).
Risk Information
cvss4
Base: 7.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
SysReptor is a fully customizable pentest reporting platform. Prior to 2025.102, there is a Stored Cross-Site Scripting (XSS) vulnerability allows authenticated users to execute malicious JavaScript in the context of other logged-in users by uploading malicious JavaScript files in the web UI. This vulnerability is fixed in 2025.102.
Risk Information
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
Description
Taiko Alethia is an Ethereum-equivalent, permissionless, based rollup designed to scale Ethereum without compromising its fundamental properties. In 2.3.1 and earlier, TaikoInbox._verifyBatches (packages/protocol/contracts/layer1/based/TaikoInbox.sol:627-678) advanced the local tid to whatever transition matched the current blockHash before knowing whether that batch would actually be verified. When the loop later broke (e.g., cooldown window not yet passed or transition invalidated), the function still wrote that newer tid into batches[lastVerifiedBatchId].verifiedTransitionId after decrementing batchId. Result: the last verified batch could end up pointing at a transition index from the next batch (often zeroed), corrupting the verified chain pointer.
Risk Information
cvss4
Base: 8.0
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A flaw has been found in youlaitech youlai-mall 1.0.0/2.0.0. Affected is the function getById/updateAddress/deleteAddress of the file /mall-ums/app-api/v1/addresses/. Executing manipulation can lead to improper control of dynamically-identified variables. The attack can be executed remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
Risk Information
cvss2
Base: 6.5
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
cvss3
Base: 6.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=macleods-pharmaceuticals-ltd.' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
